• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

场景:子宫内膜癌预后的签名收集

SCENE: Signature Collection for Endometrial Cancer Prognosis.

作者信息

Dugo Erica, Piva Francesco, Giulietti Matteo, Giannella Luca, Ciavattini Andrea

机构信息

Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy.

Woman's Health Sciences Department, Gynecologic Section, Polytechnic University of Marche, Ancona, Italy.

出版信息

J Cell Mol Med. 2025 Aug;29(15):e70762. doi: 10.1111/jcmm.70762.

DOI:10.1111/jcmm.70762
PMID:40754672
Abstract

Endometrial cancer (EC) is the most common malignancy of the female reproductive tract; its prognosis is difficult to predict. Despite the technique of single-cell transcriptomic analysis (scRNA-seq) returning single-cell level expression data and promising to improve the accuracy of prognosis prediction, a tool that correlates transcriptomic signatures with survival is missing. To this aim, we have created SCENE, a database that collects information to correlate EC transcriptomic signatures with patient prognosis. We performed a review of the literature present in PubMed to collect transcriptomic signatures annotated with their characteristics, differential expression between healthy and sick patients, between patients with more and less favourable prognosis, and cellular pathways in which the genes are involved, as well as references to the original studies. The analysis of about 200 studies has allowed us to obtain 700 mRNA signatures, 60 microRNA (miRNA), and 150 long non-coding RNA (lncRNA), involved in 60 molecular pathways. Each signature is annotated with its specific prognostic outcome that it influences, such as overall survival (OS), progression-free survival (PFS), relapse-free survival (RFS), and disease-specific survival (DSS). The SCENE resource collects and annotates information that is widespread in the literature to facilitate the interpretation of transcriptomic data obtained with any technique in EC. In the case of scRNA-seq data, SCENE may reveal cells predisposed to develop therapy resistance and metastasis.

摘要

子宫内膜癌(EC)是女性生殖道最常见的恶性肿瘤,其预后难以预测。尽管单细胞转录组分析技术(scRNA-seq)能返回单细胞水平的表达数据,并有望提高预后预测的准确性,但目前仍缺少一种将转录组特征与生存情况相关联的工具。为此,我们创建了SCENE数据库,该数据库收集相关信息,以将EC转录组特征与患者预后相关联。我们对PubMed中发表的文献进行了综述,收集了带有其特征注释的转录组特征、健康与患病患者之间的差异表达、预后较好与较差患者之间的差异表达、基因所涉及的细胞通路,以及原始研究的参考文献。对约200项研究的分析使我们获得了700个mRNA特征、60个微小RNA(miRNA)和150个长链非编码RNA(lncRNA),它们涉及60条分子通路。每个特征都标注了其影响的特定预后结果,如总生存期(OS)、无进展生存期(PFS)、无复发生存期(RFS)和疾病特异性生存期(DSS)。SCENE资源收集并注释了文献中广泛存在的信息,以促进对通过任何技术在EC中获得的转录组数据的解读。对于scRNA-seq数据,SCENE可能揭示易产生治疗抗性和转移的细胞。

相似文献

1
SCENE: Signature Collection for Endometrial Cancer Prognosis.场景:子宫内膜癌预后的签名收集
J Cell Mol Med. 2025 Aug;29(15):e70762. doi: 10.1111/jcmm.70762.
2
New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.从单细胞 lncRNA 表达分析中获得胶质母细胞瘤精准治疗的新见解。
J Cancer Res Clin Oncol. 2021 Jul;147(7):1881-1895. doi: 10.1007/s00432-021-03584-9. Epub 2021 Mar 11.
3
Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.鉴定甲状腺激素受体β表达缺失并具有改善生存的子宫内膜癌新型亚群。
BMC Cancer. 2020 Sep 7;20(1):857. doi: 10.1186/s12885-020-07325-y.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
The Impact of High lncRNA Expression on Clinicopathological Characteristics and Prognosis of Endometrial Cancer Patients: A Meta-Analysis.长链非编码RNA高表达对子宫内膜癌患者临床病理特征及预后的影响:一项Meta分析
Cancer Med. 2025 Mar;14(5):e70755. doi: 10.1002/cam4.70755.
6
A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.一种用于局限性透明细胞肾细胞癌的基于预后微小RNA的特征:Bio-miR研究
Br J Cancer. 2025 May 7. doi: 10.1038/s41416-025-03008-2.
7
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
8
Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer.用于子宫内膜癌治疗的淋巴结切除术或前哨淋巴结活检术。
Cochrane Database Syst Rev. 2025 Jun 10;6(6):CD015786. doi: 10.1002/14651858.CD015786.pub2.
9
Hormone replacement therapy for women previously treated for endometrial cancer.曾接受子宫内膜癌治疗的女性的激素替代疗法。
Cochrane Database Syst Rev. 2018 May 15;5(5):CD008830. doi: 10.1002/14651858.CD008830.pub3.
10
Endometrial biomarkers for the non-invasive diagnosis of endometriosis.用于子宫内膜异位症非侵入性诊断的子宫内膜生物标志物。
Cochrane Database Syst Rev. 2016 Apr 20;4(4):CD012165. doi: 10.1002/14651858.CD012165.

本文引用的文献

1
Molecular Features of HPV-Independent Cervical Cancers.人乳头瘤病毒非依赖性宫颈癌的分子特征
Pathogens. 2025 Jul 8;14(7):668. doi: 10.3390/pathogens14070668.
2
Establishment of a prognostic signature and immune infiltration characteristics for uterine corpus endometrial carcinoma based on a disulfidptosis/ferroptosis-associated signature.基于二硫键连接的铁死亡相关特征建立子宫体子宫内膜癌的预后特征及免疫浸润特征
Front Immunol. 2025 Jan 27;16:1492541. doi: 10.3389/fimmu.2025.1492541. eCollection 2025.
3
Integrating single-cell RNA-seq and bulk RNA-seq to explore prognostic value and immune landscapes of methionine metabolism-related signature in breast cancer.
整合单细胞RNA测序和批量RNA测序以探索乳腺癌中蛋氨酸代谢相关特征的预后价值和免疫景观。
Front Genet. 2025 Jan 14;15:1521269. doi: 10.3389/fgene.2024.1521269. eCollection 2024.
4
Identification of a pancreatic stellate cell gene signature and lncRNA interactions associated with type 2 diabetes progression.与2型糖尿病进展相关的胰腺星状细胞基因特征及长链非编码RNA相互作用的鉴定
Front Endocrinol (Lausanne). 2025 Jan 13;15:1532609. doi: 10.3389/fendo.2024.1532609. eCollection 2024.
5
Cancer statistics, 2025.2025年癌症统计数据。
CA Cancer J Clin. 2025 Jan-Feb;75(1):10-45. doi: 10.3322/caac.21871. Epub 2025 Jan 16.
6
MarkerDB 2.0: a comprehensive molecular biomarker database for 2025.MarkerDB 2.0:面向2025年的综合分子生物标志物数据库。
Nucleic Acids Res. 2025 Jan 6;53(D1):D1415-D1426. doi: 10.1093/nar/gkae1056.
7
Integrated Identification and Immunotherapy Response Analysis of the Prognostic Signature Associated With m6A, Cuproptosis-Related, Ferroptosis-Related lncRNA in Endometrial Cancer.子宫内膜癌中 m6A、铜死亡相关、铁死亡相关 lncRNA 预后特征的综合鉴定及免疫治疗反应分析。
Cancer Rep (Hoboken). 2024 Sep;7(9):e70009. doi: 10.1002/cnr2.70009.
8
A Comparison of Tools That Identify Tumor Cells by Inferring Copy Number Variations from Single-Cell Experiments in Pancreatic Ductal Adenocarcinoma.通过推断胰腺导管腺癌单细胞实验中的拷贝数变异来识别肿瘤细胞的工具比较
Biomedicines. 2024 Aug 5;12(8):1759. doi: 10.3390/biomedicines12081759.
9
Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma.基于免疫原性细胞死亡相关长链非编码RNA的特征识别以预测子宫内膜癌患者的预后和免疫活性
Transl Cancer Res. 2024 Jun 30;13(6):2913-2937. doi: 10.21037/tcr-23-2243. Epub 2024 Jun 27.
10
Copy number variations in endometrial cancer: from biological significance to clinical utility.子宫内膜癌中的拷贝数变异:从生物学意义到临床应用。
Int J Gynecol Cancer. 2024 Jul 1;34(7):1089-1097. doi: 10.1136/ijgc-2024-005295.